We are live on ! Find out more

SI

Shoulder Innovations Inc

SI

Market cap $362M

17.37 USD

-0.24

1.36%

At close Updated Sep 23, 4:00 PM EDT

1 day

-1.36%

5 days

-3.87%

1 month

-21.83%

3 months

-9.95%

6 months

20.54%

Year to date

20.88%

1 year

29.82%

5 years

15.42%

10 years

15.42%

About: Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.

Employees: 75

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 7.7%

Neutral 92.3%

Negative 0%

Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch

Second Product Introduction on New Line of Technologies for Metal-Sensitive Patients GRAND RAPIDS, Mich., Sept. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the N-22 Humeral Head, a titanium implant option for patients with metal hypersensitivity.

Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch

Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures

GRAND RAPIDS, Mich., Sept. 9, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has entered into an exclusive collaboration with ALM Ortho, Inc. ("ALM Ortho"), a leader in additive manufacturing of titanium orthopedic implants, to introduce a bespoke implant for the treatment of severe shoulder deformity and other highly complex revision cases, circumstances for which no adequate solution currently exists.

Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures

Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience

GRAND RAPIDS, Mich., Sept. 8, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that it has entered into a settlement agreement with Catalyst OrthoScience Inc. ("Catalyst") to resolve all outstanding patent litigation between the two companies.

Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

GRAND RAPIDS, Mich., Sept. 1, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in a fireside chat at the Morgan Stanley 24th Annual Healthcare Conference.

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

GRAND RAPIDS, Mich., Aug. 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026.

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations NYSE: SI reported second-quarter net revenue of $17.2 million, up 56% from $11 million a year earlier, as the company added surgeons, expanded use among existing customers and advanced several product launches. The company raised its full-year 2026 revenue outlook to $67 million to $69 million, from a prior range of $65 million to $68 million.

Shoulder Innovations Q2 Earnings Call Highlights

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations, Inc. (SI) came out with a quarterly loss of $0.46 per share in line with the Zacks Consensus Estimate. This compares to a loss of $64.47 per share a year ago.

Shoulder Innovations, Inc. (SI) Reports Q2 Loss, Beats Revenue Estimates

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

Generates First Half 2026 Revenue Growth of 60% GRAND RAPIDS, Mich., Aug. 6, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2026.

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook

See News Rankings

Price charts implemented using Lightweight Charts™